How big is the Inhalation Anesthetics Market?

The Inhalation Anesthetics Market size is expected to reach USD 1.38 billion in 2024 and grow at a CAGR of 4.57% to reach USD 1.74 billion by 2029. Read More

What is the current Inhalation Anesthetics Market size?

In 2024, the Inhalation Anesthetics Market size is expected to reach USD 1.38 billion. Read More

Who are the key players in Inhalation Anesthetics Market?

Baxter, Lunan Pharmaceutical Group Co. Ltd, Piramal Enterprises Limited, Fresenius Kabi and Dechra Pharmaceuticals PLC (Halocarbon Life Sciences LLC) are the major companies operating in the Inhalation Anesthetics Market. Read More

Which is the fastest growing region in Inhalation Anesthetics Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Inhalation Anesthetics Market?

In 2024, the North America accounts for the largest market share in Inhalation Anesthetics Market. Read More

What years does this Inhalation Anesthetics Market cover, and what was the market size in 2023?

In 2023, the Inhalation Anesthetics Market size was estimated at USD 1.32 billion. The report covers the Inhalation Anesthetics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Inhalation Anesthetics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Inhalation Anesthetics Market Share

Statistics for the 2023 & 2024 Inhalation Anesthetics market share, created by Mordor Intelligence™ Industry Reports. Inhalation Anesthetics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Inhalation Anesthetics Industry

Market players in the inhalation anesthetics market are focusing on the expansion of their product portfolios by adopting inorganic growth strategies, such as acquisitions, mergers, and partnerships. The key market players that hold significant shares in the inhalation anesthetics market include Abbvie Inc., Baxter, Piramal Enterprises Ltd, and Hikma Pharmaceuticals PLC, among others.